✦ LIBER ✦

Metabolic syndrome in high cardiovascular risk patients

✍ Scribed by Giovanni Gaudio; Alberto Schizzarotto; Pietro Margaroli; Piermario Bossi; Giuditta Riganti; Ivano Cosini; Adriano Daverio; Franco Rotolo; Luigina Guasti

Book ID: 116208921
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 102 KB
Volume: 18
Category: Article
ISSN: 0895-7061
DOI: 10.1016/j.amjhyper.2005.03.297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High prevalence of cardiovascular risk f

High prevalence of cardiovascular risk factors, metabolic syndrome and cardiovascular disease in patients with knee osteoarthritis in a primary care setting

✍ N. Navarro; C. Orellana; M. Moreno; C. Galisteo; J. Gratacós; M. Larrosa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

High prevalence of the metabolic syndrom

High prevalence of the metabolic syndrome and association with novel cardiovascular risk factors in patients with type 2 diabetes

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Efficacy and safety of dalcetrapib in ty

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk

✍ A. F. H. Stalenhoef; M. H. Davidson; J. G. Robinson; T. Burgess; R. Duttlinger-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Metabolic syndrome is an independent pre

Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease

✍ Jan-Peter van Kuijk; Willem-Jan Flu; Michel Chonchol; Jeroen J. Bax; Hence J.M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 320 KB

High sensitive serum C-reactive protein

High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome

✍ Fatma Ferda Verit 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 184 KB

MS212 ADELINA: EFFECTS OF HIGH-DOSE ATOR

MS212 ADELINA: EFFECTS OF HIGH-DOSE ATORVASTATIN ON ESTIMATED CARDIOVASCULAR RISK AND ADIPOKINE PRODUCTION IN DYSLIPAEMIC NON-DIABETIC PATIENTS WITH METABOLIC SYNDROME

✍ Martinez-Martin, F.; Soriano Perera, P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB